FDA Inspection 1133675 — Johns Hopkins Medicine Institutional Review Boards
The FDA completed an inspection of Johns Hopkins Medicine Institutional Review Boards on October 30, 2020 in Baltimore, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 30, 2020
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Baltimore, MD (United States)
Additional Details
IRB